Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Bartalena

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Clinical Endocrinology|February 13, 2010
What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?Luigi Bartalena
Journal of Endocrinological Investigation|May 31, 2002
Smoking and Graves' diseaseLuigi Bartalena
Nuclear Medicine Communications|November 2, 2002
Radioiodine therapy and Graves' ophthalmopathyLuigi Bartalena
Ophthalmic Plastic and Reconstructive Surgery|July 16, 2014
Commentary: rituximab, adalimumab, etanercept, tocilizumab--are biologics the future for Graves' orbitopathy?Luigi Bartalena
European Thyroid Journal|May 1, 2014
Graves' orbitopathy: imperfect treatments for a rare diseaseLuigi Bartalena
European Thyroid Journal|December 8, 2022
Role of teprotumumab in the treatment of active moderate-to-severe Graves' orbitopathyLuigi Bartalena
The Journal of Clinical Endocrinology and Metabolism|September 9, 2005
Editorial: glucocorticoids for Graves' ophthalmopathy: how and whenLuigi Bartalena
The Journal of Clinical Endocrinology and Metabolism|December 31, 2010
The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathyLuigi Bartalena
Ophthalmology|March 8, 2003
Orbital radiation therapy for Graves' ophthalmopathyLuigi Bartalena
Nature Reviews. Endocrinology|October 16, 2013
Diagnosis and management of Graves disease: a global overviewLuigi Bartalena
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Clinical Endocrinology|February 13, 2010
What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?Luigi Bartalena
Journal of Endocrinological Investigation|May 31, 2002
Smoking and Graves' diseaseLuigi Bartalena
Nuclear Medicine Communications|November 2, 2002
Radioiodine therapy and Graves' ophthalmopathyLuigi Bartalena
Ophthalmic Plastic and Reconstructive Surgery|July 16, 2014
Commentary: rituximab, adalimumab, etanercept, tocilizumab--are biologics the future for Graves' orbitopathy?Luigi Bartalena
European Thyroid Journal|May 1, 2014
Graves' orbitopathy: imperfect treatments for a rare diseaseLuigi Bartalena
European Thyroid Journal|December 8, 2022
Role of teprotumumab in the treatment of active moderate-to-severe Graves' orbitopathyLuigi Bartalena
The Journal of Clinical Endocrinology and Metabolism|September 9, 2005
Editorial: glucocorticoids for Graves' ophthalmopathy: how and whenLuigi Bartalena
The Journal of Clinical Endocrinology and Metabolism|December 31, 2010
The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathyLuigi Bartalena
Ophthalmology|March 8, 2003
Orbital radiation therapy for Graves' ophthalmopathyLuigi Bartalena
Nature Reviews. Endocrinology|October 16, 2013
Diagnosis and management of Graves disease: a global overviewLuigi Bartalena
Pageof 14